UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000028512
Receipt number R000032629
Scientific Title Evaluation of bone remodeling after total hip arthroplasty using Initia Stem
Date of disclosure of the study information 2017/08/03
Last modified on 2023/08/24 14:11:40

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Evaluation of bone remodeling after total hip arthroplasty using Initia Stem

Acronym

Bone remodeling after THA using Initia Stem

Scientific Title

Evaluation of bone remodeling after total hip arthroplasty using Initia Stem

Scientific Title:Acronym

Bone remodeling after THA using Initia Stem

Region

Japan


Condition

Condition

Secondary osteoarthritis caused by hip dysplasia or osteonecrosis of the femoral head

Classification by specialty

Orthopedics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To examine the change of bone mineral density around Initia Stem after total hip arthroplasty in comparison with that around Perfix HA 910 stem based on Randomized Controlled Trial.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Comparison of the change of bone mineral density around the stem between Initia stem and Perfix HA 910 stem based on previous report describing the change of bone mineral density around cement-less stem.

Key secondary outcomes

To examine the relationship of the change of bone mineral density around the cement-less stem with investigation items, including background, clinical assessment, radiograph, and patient-reported outcome.


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

Active

Stratification

NO

Dynamic allocation

NO

Institution consideration


Blocking

YES

Concealment

Numbered container method


Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Device,equipment

Interventions/Control_1

Total hip arthroplasty using Initia Stem

Interventions/Control_2

Total hip arthroplasty using Perfix HA 910 stem

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

75 years-old >=

Gender

Male and Female

Key inclusion criteria

1) Primary total hip arthroplasty
2) Age: 20-75 years old
3) Male and Female
4) Patients with the ability of consent and writing
5) Patients who can visit hospital as scheduled during the research period

Key exclusion criteria

1) Patients with immature bone structure
2) Patients with the loss of abduction muscle in affected leg
3) Patients with insufficient bone mineral density (e.g. Corticosteroid-induced metabolic bone disease)
4) Patients with insufficient skin covering around the hip joint
5) Patients with neuromuscular disease (e.g. Charcot disease) in affected leg
6) Patients with the infection (e.g. osteomyelitis in proximal femur or purulent infection in the hip joint)
7) Patients with stovepipe-like femur
8) Patients with radiation osteonecrosis of acetabulum
9) Patients with systemic or local infection
10) Patients with vascular interruption in affected leg
11) Patients without the ability of walking at the postoperative time
12) Suspicious patients with metal allergy
13) Pregnant patients, pregnant suspicious patients, or patients who hope for pregnancy
14) Patients with the disease which can affect consent or evaluation of the study, including dementia, schizophrenia, depression, panic disorder, or generalized anxiety disorder
15) Patients who need to undergo the lower extremity surgery within six months after participating in the study, including total hip arthroplasty and total knee arthroplasty
16) Patients who underwent the lower extremity surgery within six months before participating in the study, including total hip arthroplasty, total knee arthroplasty, or osteotomy
17) Patients who doctors judged unsuitable for the study



Target sample size

200


Research contact person

Name of lead principal investigator

1st name Yasuharu
Middle name
Last name Nakashima

Organization

Graduate School of Medical Sciences, Kyushu University

Division name

Department of Orthopaedic Surgery

Zip code

812-8582

Address

3-1-1 Maidashi, Higashi-ku, Fukuoka

TEL

092-642-5488

Email

yasunaka@ortho.med.kyushu-u.ac.jp


Public contact

Name of contact person

1st name Goro
Middle name
Last name Motomura

Organization

Graduate School of Medical Sciences, Kyushu University

Division name

Department of Orthopaedic Surgery

Zip code

812-8582

Address

3-1-1 Maidashi, Higashi-ku, Fukuoka

TEL

092-642-5488

Homepage URL


Email

goromoto@ortho.med.kyushu-u.ac.jp


Sponsor or person

Institute

Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Kyushu University

Institute

Department

Personal name



Funding Source

Organization

Nothing in particular

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Research Support Division, Kyushu University

Address

3-1-1 Maidashi, Higashi-ku, Fukuoka

Tel

092-642-5082

Email

byskenkyu@jimu.kyushu-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

九州大学病院(福岡県)


Other administrative information

Date of disclosure of the study information

2017 Year 08 Month 03 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 08 Month 03 Day

Date of IRB

2017 Year 06 Month 21 Day

Anticipated trial start date

2017 Year 09 Month 01 Day

Last follow-up date

2022 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 08 Month 03 Day

Last modified on

2023 Year 08 Month 24 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000032629


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name